Category Archives: Insulins

Recent Research: Adocia & Lilly Announce Positive Results For Study on Ultra-Rapid Insulin

Lyon and Indianapolis, May 31, 2016 – Adocia (Euronext Paris: ADOC) and Eli Lilly and Company (NYSE: LLY) announced today positive topline results from a Phase 1 clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation

Read More

FDA Approves Two Novo Nordisk Insulin Medications

In late September 2015, the FDA finally approved Tresiba, a diabetes drug from Novo Nordisk. This once daily medication is a long-acting  drug that was previously rejected in 2013 after the FDA requested more data about the heart risks  … Read More